Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
13.08.25
/
50%
€104.00
Target price
13.08.26
€121.61
Performance (%)
-18.71%
Price
12.06.26
€82.80
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -18.71%. This prediction currently runs until 13.08.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 1.471% | 1.471% |
| iShares Core DAX® | 0.271% | 2.504% |
| iShares Nasdaq 100 | 1.884% | 3.490% |
| iShares Nikkei 225® | 3.579% | 8.127% |
| iShares S&P 500 | 0.151% | 1.918% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $114.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat